}

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Extensive impact of non-antibiotic drugs on human gut bacteria.
    Nature (Nature ) Vol: 555 Issue 7698 Pages: 623-628
    Pub: 2018 Mar 29 Epub: 2018 Mar 19
    • Maier L
    • Pruteanu M
    • Kuhn M
    • Zeller G
    • Telzerow A
    • Anderson EE
    • Brochado AR
    • Fernandez KC
    • Dose H
    • Mori H
    • Patil KR
    • Bork P
    • Typas A

  2. The antimicrobial resistance pattern of cultured human methanogens reflects the unique phylogenetic position of archaea.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 66 Issue 9 Pages: 2038-44
    Pub: 2011 Sep Epub: 2011 Jun 16
    • Dridi B
    • Fardeau ML
    • Ollivier B
    • Raoult D
    • Drancourt M

  3. Additional sources and private correspondance
    Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12
    Pub: 2018 Epub:
  4. Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach
    Clinical and Experimental Gastroenterology (Clin Exp Gastroenterol ) Vol: 8 Issue Pages: 309-325
    Pub: 2015 Dec 4 Epub: 2015 Dec 4
    • Soldi S
    • Vasileiadis S
    • Uggeri F
    • Campanale M
    • Morelli L
    • Fogli MV
    • Calanni F
    • Grimaldi M
    • Gasbarrini A

  5. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
    International journal of food microbiology (Int J Food Microbiol ) Vol: 98 Issue 2 Pages: 211-7
    Pub: 2005 Feb 1 Epub:
    • Zhou JS
    • Pillidge CJ
    • Gopal PK
    • Gill HS

  6. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
    World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 47 Pages: 8355-8366
    Pub: 2017 Dec 21 Epub:
    • Kaji K
    • Takaya H
    • Saikawa S
    • Furukawa M
    • Sato S
    • Kawaratani H
    • Kitade M
    • Moriya K
    • Namisaki T
    • Akahane T
    • Mitoro A
    • Yoshiji H

  7. Antibiotic susceptibility of potentially probiotic Lactobacillus species.
    Journal of food protection (J Food Prot ) Vol: 61 Issue 12 Pages: 1636-43
    Pub: 1998 Dec Epub:
    • Charteris WP
    • Kelly PM
    • Morelli L
    • Collins JK

  8. Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract.
    Letters in applied microbiology (Lett Appl Microbiol ) Vol: 26 Issue 5 Pages: 333-7
    Pub: 1998 May Epub:
    • Charteris WP
    • Kelly PM
    • Morelli L
    • Collins JK

  9. Rifaximin modulates the colonic microbiota of patients with Crohn`s disease: an in vitro approach using a continuous culture colonic model system.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 65 Issue 12 Pages: 2556-65
    Pub: 2010 Dec Epub: 2010 Sep 18
    • Maccaferri S
    • Vitali B
    • Klinder A
    • Kolida S
    • Ndagijimana M
    • Laghi L
    • Calanni F
    • Brigidi P
    • Gibson GR
    • Costabile A

  10. Review article: the antimicrobial effects of rifaximin on the gut microbiota.
    Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther ) Vol: 43 Suppl 1 Issue Pages: 3-10
    Pub: 2016 Jan Epub:
    • DuPont HL

Full list available by paid subscriptions

For More information see this summary.


This site is a free site for non-commercial use and intended to stay a free site for individuals and practioning individual physicians!

Reverse engineering, data scraping and spidering are strictly provided and will be prosecuted under 18 U.S.C. ┬ž 1030(e)(6) and other statutes. Licensing with an API is available.

If this site is really helpful and you are loaded with money -- Amazon Gift cards are always appreciated to defer operating costs.;-)